Immunogenicity and safety of a quadrivalent influenza vaccine in children and adolescents in Taiwan: A phase III open-label trial

In conclusion, this study showed that the 2013–2014 Northern Hemisphere formulation of the intramuscular IIV4 was immunogenic and well tolerated by children and adolescents 9–17years of age.
Source: Trials in Vaccinology - Category: Infectious Diseases Source Type: research